Epstein Secrets

From: James Meiskin < To: Lesley Groff Subject: Re: Confidential Date: Wed, 02 Jul 2014 14:07:41 +0000 Thank you. James Sent from my iPhone On Jul 1, 2014, at 7:33 AM, Lesley Groff <

From: James Meiskin < To: Lesley Groff Subject: Re: Confidential Date: Wed, 02 Jul 20

logies that are worthy of development. RVC has already agreed to finance the first (MAR) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

From: James Meiskin To: Lesley Groff c; Subject: Re: Confidential Date: Thu, 29 May 2014 14:04:49 +0000 Hope we can reschedule. Thank you. James Sent from my iPhone On May 29, 2014,

From: James Meiskin To: Lesley Groff c; Subject: Re: Confidential Date: Thu, 29 May

ogies that are worthy of development. RVC has already agreed to finance the first (MALI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

From: Lesley Groff <1 To: Jeffrey Epstein cti Subject: Fwd: Confidential Date: Wed, 21 May 2014 13:28:20 +0000 Attachments: DaCart_Presentation.pptx Begin forwarde

From: Lesley Groff <1 To: Jeffrey Epstein cti Subject: Fwd: Confid

logies that are worthy of development. RVC has already agreed to finance the first (MALI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

From: Lesley Groff To: Jeffrey Epstein <1 Subject: James Meisken/David Carter Date: Wed, 29 Oct 2014 13:38:59 +0000 Attachments: DaCart_Presentation Jul 7 2014.pdf

From: Lesley Groff To: Jeffrey Epstein <1 Subject: James Meisken/

logies that are worthy of development. RVC has already agreed to finance the first (MAJI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

From: Lesley Groff <1 To: David Carter c4 Subject: Re: Investment Opportunities Date: Fri, 06 Mar 2015 15:42:18 +0000 terrific. I will forward on...thanks On Mar 6

From: Lesley Groff <1 To: David Carter c4 Subject: Re: Investment

ly. It will be a challenge to find investors, sensitive to risk and return, to provide OvationBio the capital it needs to do its early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the bigges

From: Lesley Groff To: Jeffrey Epstein CC <1 Subject: Reminder: James Meisken and David carter Date: Thu, 30 Oct 2014 11:44:44 +0000 Attachments: DaCart_Presentati

From: Lesley Groff To: Jeffrey Epstein CC <1 Subject: Reminder: J

logies that are worthy of development. RVC has already agreed to finance the first (MALI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit

From: Lesley Groff To: Jeffrey Epstein <jeevacationggmail.com> Subject: James Meisken/David Carter Date: Wed, 29 Oct 2014 13:38:59 +0000 Attachments: DaCart_Presenta

From: Lesley Groff To: Jeffrey Epstein <jeevacationggmail.com> Subj

logies that are worthy of development. RVC has already agreed to finance the first (MAJI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capit